Company Overview of SanBio, Inc.
SanBio, Inc. develops regenerative therapies for neurological disorders. Its product pipeline includes SB623, which integrates into the tissue and reverses neural damage; SB618 for the treatment of conditions that affect the myelin sheath of neurons, such as multiple sclerosis and spinal cord injury; and SB308, which uses donor bone marrow to create muscle progenitor cells. The company’s products are used for the treatment of various neurological disorders, including stroke, spinal cord injury, Parkinson's disease, and multiple sclerosis. SanBio, Inc. was founded in 2001 and is based in Mountain View, California. SanBio, Inc. operates as a subsidiary of SanBio Company Limited.
231 South Whisman Road
Mountain View, CA 94041-1522
Founded in 2001
Key Executives for SanBio, Inc.
SanBio, Inc. Key Developments
Similar Private Companies By Industry
|Vaxart, Inc.||United States|
|Correlagen Diagnostics, Inc.||United States|
|Indigo Biosciences, Inc.||United States|
|Dilyx Biotechnologies, LLC||United States|
|Gahaga Biosciences, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact SanBio, Inc., please visit www.san-bio.com. Company data is provided by Capital IQ. Please use this form to report any data issues.